Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study - Karampeazis, A; Voutsina, A; Souglakos, J (Cancer, 2013)
, et al.